Search Results - "Gesson, C"

58 Pharmacokinetics and safety of a novel CFTR corrector molecule GLPG2222 in subjects with cystic fibrosis (CF): results from a phase Ib study by Van de Steen, O, De Boeck, K, Vermeulen, F, Geller, D.E, De Kock, H, Kanters, D, Gesson, C, Namour, F

Get full text

WS13.6 GLPG1837 in subjects with cystic fibrosis (CF) and the G551D mutation: results from a phase II study (SAPHIRA1) by Davies, J, Bell, S.C, Van Koningsbruggen-Rietschel, S, McKone, E.F, Macgregor, G, Drevinek, P, Conrath, K, de Kock, H, Gesson, C, Kanters, D, Van de Steen, O

Get full text